Specifically, low MTUS1 expression was associated with clinicopathological parameters related to cancer proliferation (tumor size and Ki-67 proliferation index) and metastasis (lymphovascular invasion and lymph node metastasis) in our study. Here, MTUS1 is linked to metastatic malignant neoplasm in the lymph nodes.